X-ray crystal structure of the bovine alpha-chymotrypsin/eglin c complex at 2.6 A resolution. 1990

M Bolognesi, and L Pugliese, and G Gatti, and F Frigerio, and A Coda, and L Antolini, and H P Schnebli, and E Menegatti, and G Amiconi, and P Ascenzi
Department of Genetics and Microbiology, University of Pavia, Italy.

The crystal structure of the molecular complex formed by bovine alpha-chymotrypsin and the recombinant serine proteinase inhibitor eglin c from Hirudo medicinalis has been solved using monoclinic crystals of the complex, reported previously. Four circle diffractometer data at 3.0 A resolution were employed to determine the structure by molecular replacement techniques. Bovine alpha-chymotrypsin alone was used as the search model; it allowed us to correctly orient and translate the enzyme in the unit cell and to obtain sufficient electron density for positioning the eglin c molecule. After independent rigid body refinement of the two complex components, the molecular model yielded a crystallographic R factor of 0.39. Five iterative cycles of restrained crystallographic refinement and model building were conducted, gradually increasing resolution. The current R factor at 2.6 A resolution (diffractometer data) is 0.18. The model includes 56 solvent molecules. Eglin c binds to bovine alpha-chymotrypsin in a manner consistent with other known serine proteinase/inhibitor complex structures. The reactive site loop shows the expected conformation for productive binding and is in tight contact with bovine alpha-chymotrypsin between subsites P3 and P'2; Leu 451 acts as the P1 residue, located in the primary specificity S1 site of the enzyme. Hydrogen bonds equivalent to those observed in complexes of trypsin(ogen) with the pancreatic basic- and secretory-inhibitors are found around the scissile peptide bond.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002918 Chymotrypsin A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side. Alpha-Chymotrypsin Choay,Alphacutanée,Avazyme
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014961 X-Ray Diffraction The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Xray Diffraction,Diffraction, X-Ray,Diffraction, Xray,Diffractions, X-Ray,Diffractions, Xray,X Ray Diffraction,X-Ray Diffractions,Xray Diffractions
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine

Related Publications

M Bolognesi, and L Pugliese, and G Gatti, and F Frigerio, and A Coda, and L Antolini, and H P Schnebli, and E Menegatti, and G Amiconi, and P Ascenzi
May 1993, The Journal of biological chemistry,
M Bolognesi, and L Pugliese, and G Gatti, and F Frigerio, and A Coda, and L Antolini, and H P Schnebli, and E Menegatti, and G Amiconi, and P Ascenzi
September 1992, FEBS letters,
M Bolognesi, and L Pugliese, and G Gatti, and F Frigerio, and A Coda, and L Antolini, and H P Schnebli, and E Menegatti, and G Amiconi, and P Ascenzi
June 2010, Acta crystallographica. Section D, Biological crystallography,
M Bolognesi, and L Pugliese, and G Gatti, and F Frigerio, and A Coda, and L Antolini, and H P Schnebli, and E Menegatti, and G Amiconi, and P Ascenzi
October 2007, Proceedings of the National Academy of Sciences of the United States of America,
M Bolognesi, and L Pugliese, and G Gatti, and F Frigerio, and A Coda, and L Antolini, and H P Schnebli, and E Menegatti, and G Amiconi, and P Ascenzi
August 1980, Nature,
M Bolognesi, and L Pugliese, and G Gatti, and F Frigerio, and A Coda, and L Antolini, and H P Schnebli, and E Menegatti, and G Amiconi, and P Ascenzi
July 1998, European journal of biochemistry,
M Bolognesi, and L Pugliese, and G Gatti, and F Frigerio, and A Coda, and L Antolini, and H P Schnebli, and E Menegatti, and G Amiconi, and P Ascenzi
September 1993, Science in China. Series B, Chemistry, life sciences & earth sciences,
M Bolognesi, and L Pugliese, and G Gatti, and F Frigerio, and A Coda, and L Antolini, and H P Schnebli, and E Menegatti, and G Amiconi, and P Ascenzi
August 1991, The Journal of biological chemistry,
M Bolognesi, and L Pugliese, and G Gatti, and F Frigerio, and A Coda, and L Antolini, and H P Schnebli, and E Menegatti, and G Amiconi, and P Ascenzi
August 1983, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
M Bolognesi, and L Pugliese, and G Gatti, and F Frigerio, and A Coda, and L Antolini, and H P Schnebli, and E Menegatti, and G Amiconi, and P Ascenzi
September 1984, Journal of molecular biology,
Copied contents to your clipboard!